Evan Bayless

Evan Bayless, MBA, serves as the Senior Director of US Marketing, Alzheimer's Disease at Eisai US since March 2023, where responsibilities include leading brand strategy and lifecycle planning, alongside cross-functional initiatives in neurology and primary care. Prior to Eisai, Evan held various senior roles at Eli Lilly and Company, notably as Senior Director of Global Marketing for the Migraine Portfolio, where leadership encompassed brand optimization and cross-market collaboration. Additional experience includes consulting roles in global marketing at Vestergaard and extensive training and marketing positions at Eli Lilly, underpinned by an MBA from UNC Kenan-Flagler Business School and a BA from Wabash College.